Denali Therapeutics Inc. (FRA:4DN)
Germany · Delayed Price · Currency is EUR 17.00
+0.41 (2.47%)
At close: Nov 28, 2025
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of €2.29 billion as of December 2, 2025. Its market cap has decreased by -43.18% in one year.
Market Cap
2.29B
Enterprise Value
1.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€17.00
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from 1.61B to 2.29B, an increase of 42.72%. That is a compound annual growth rate of 4.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 2.29B | -19.13% |
| Dec 31, 2024 | 2.83B | 5.59% |
| Dec 29, 2023 | 2.68B | -24.08% |
| Dec 30, 2022 | 3.53B | -26.21% |
| Dec 31, 2021 | 4.79B | -41.67% |
| Dec 31, 2020 | 8.21B | 450.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |